Related Experiment Video
Updated: Mar 27, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal
Olurotimi O Mesubi1, Mark E Anderson2
1Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA Department of Medicine, The Johns Hopkins University School of Medicine, 1830 E. Monument Street, Suite 9026, Baltimore, MD 21287, USA.
Abstract:
CaMKII is a serine-threonine protein kinase that is abundant in myocardium. Emergent evidence suggests that CaMKII may play an important role in promoting atrial fibrillation (AF) by targeting a diverse array of proteins involved in membrane excitability, cell survival, calcium homeostasis, matrix remodelling, inflammation, and metabolism. Furthermore, CaMKII inhibition appears to protect against AF in animal models and correct proarrhythmic, defective intracellular Ca(2+) homeostasis in fibrillating human atrial cells. This review considers current concepts and evidence from animal and human studies on the role of CaMKII in AF.
Insights
Calcium-calmodulin dependent protein kinase II (CaMKII) may promote atrial fibrillation (AF) by affecting various cellular processes. Inhibiting CaMKII shows promise in protecting against AF and correcting calcium handling in human atrial cells.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Calcium-calmodulin dependent protein kinase II (CaMKII) is abundant in heart muscle.
- Emerging evidence implicates CaMKII in atrial fibrillation (AF) pathogenesis.
Purpose of the Study:
- To review current evidence on CaMKII's role in AF.
- To explore CaMKII's molecular targets and therapeutic potential in AF.
Main Methods:
- Literature review of animal and human studies.
- Analysis of CaMKII's impact on protein targets related to AF.
Main Results:
- CaMKII targets proteins involved in membrane excitability, cell survival, calcium homeostasis, matrix remodeling, inflammation, and metabolism.
- CaMKII inhibition demonstrates protective effects against AF in animal models.
- CaMKII inhibition corrects defective intracellular calcium handling in human atrial cells.
Conclusions:
- CaMKII is a significant contributor to AF development and progression.
- Targeting CaMKII represents a potential therapeutic strategy for managing AF.
More Related Videos
10:39Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
09:37Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Chambers of the Heart
Deoxygenated blood from the body is received in the right...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Heart Failure II: Pathophysiology